Rilogrotug

• Description :

  Rilogrotug (AV-380) is a humanized IgG1 monoclonal antibody targeting GDF15[1].

• Product Name Alternative :

  AV-380

• UNSPSC :

  12352203

• Target :

  TGF-beta/Smad

• Related Pathways :

  Stem Cell/Wnt; TGF-beta/Smad

• Applications :

  Cancer-Kinase/protease

• Field of Research :

  Cancer

• Purity :

  99.9

• Smiles :

  [Rilogrotug]

• Molecular Weight :

  (145.71 kDa)

• References & Citations :

  [1]Arvind Chaudhry, et al. A phase 1b dose escalation study of AV-380 in combination with standard of care chemotherapy in metastatic cancer patients (pts) with cachexia and elevated GDF-15 levels. Therapeutic Agents: Biological| December 01 2023.

• Shipping Conditions :

  Dry Ice

• Storage Conditions :

  -80°C

• Scientific Category :

  Inhibitory Antibodies

• Clinical Information :

  Phase 1

• CAS Number :

  [2894138-72-6]